Estrogen and progesterone play an important role in the development and implantation of preimplantation embryos. However, it is controversial whether these hormones act directly on the embryos. The effects of these hormones depend on the existence of their specific receptors. To determine whether estrogen receptor (ER) There are no reports of natural mutations that result in either deficient estrogen synthesis or resistance to estrogen action. This contrasts with testosterone synthesis and action, where single-gene mutations that interfere with both processes have been characterized in many species. This difference has led George and Wilson (1) to suggest that such estrogen-related mutations may be lethal at an early stage of development.
There are no reports of natural mutations that result in either deficient estrogen synthesis or resistance to estrogen action. This contrasts with testosterone synthesis and action, where single-gene mutations that interfere with both processes have been characterized in many species. This difference has led George and Wilson (1) to suggest that such estrogen-related mutations may be lethal at an early stage of development.
Estrogen and progesterone play key roles in the establishment and maintenance of pregnancy. Elimination of these hormones from pregnant animals causes deleterious effects on the development and implantation of the embryos. Hypophysectomy of pregnant rats was shown to result in the delayed entry of eggs into the uterus, expulsion of eggs from the uterus, and retarded development of eggs. Injection of estrone and progesterone significantly reversed this effect (2) . Delayed implantation has been observed in ovariectomized mice treated with progesterone only (3) . Dormant blastocysts can be reactivated by the injection of estrogen (4, 5) . Estrogen and progesterone stimulate the metabolism of delayed implantation mouse embryos (6) . It appears to be important to maintain the concentrations of estrogen and progesterone at appropriate levels relative to each other. Elevated ratios of estradiol to progesterone were shown to inhibit blastocyst metabolism and implantation (7) . Since these experiments were performed on ovariectomized animals receiving exogenous hormones, it is not clear whether the hormones acted directly on the embryo or indirectly through the mother's reproductive tract. Some authors claimed that the effects were indirect, since retardation of
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embryo development and inhibition of implantation were observed when embryos were grown in oviductal fluid obtained from estrogen-treated, ovariectomized mice, whereas no such effects were observed when embryos were grown in defined medium with estrogen (8) . In contrast, studies by Smith (9) showed that embryos treated with estrogen in vitro had significantly higher implantation rates when transferred to foster mothers receiving only progesterone, suggesting that estrogen acts directly on the embryo. To obtain an environment without the complication of maternal effects, some investigators turned to in vitro culturing of embryos. Under these conditions, estrogen was shown to affect the uptake and incorporation of nucleic acid precursors (10, 11) and amino acids (12) by mouse blastocysts. It was also shown that antiestrogen CI 628 and aromatase inhibitor 1,4,6-androstatriene-3,17-dione inhibited the development of mouse embryos (13, 14) . This blockage was alleviated by the coadministration of 17,3estradiol. These results support the idea that estrogen affects the embryo directly.
Estrogen and progesterone elicit their functions by binding to their specific receptors. The receptors become activated upon hormone binding and serve as transcription factors that modulate the expression of their target genes (15) . For estrogen and progesterone to have any direct effect on the embryo, the receptors for these hormones must be present in the embryo. A demonstration of the expression of estrogen receptor (ER) and progesterone receptor (PR) in preimplantation embryos would provide a basis for the direct effect of estrogen and progesterone on the embryo.
We examined the levels of both ER and PR mRNA during preimplantation development by using reverse transcription (RT)-PCR. We found that ER and PR genes were expressed differentially in the preimplantation mouse embryo. The results for ER contrast with a recent report that preimplantation mouse embryos themselves did not express the ER gene even though maternal message was detected in the oocyte (16 100 pmol of random hexamer (Pharmacia), 1 mM each dNTP, and 12 units of avian myeloblastosis virus reverse transcriptase (Promega). A portion of the RT product containing RNA from the same amount of embryos was then subjected to PCR in a DNA thermal cycler (model 480, Perkin-Elmer/Cetus). A 100-,l reaction mixture included 50 mM KCl, 10 mM Tris HCl (pH 9.0 at 25°C), 0.1% Triton X-100, 4 mM MgCl2, 200 ,uM each deoxynucleotide, 2.5 units of Taq DNA polymerase (Promega), and 14 nM each primer. After 15-20 cycles, additional primers were added to reach a final concentration of 190 nM, followed by another [30] [31] [32] [33] [34] [35] cycles. The cycling profile was 94°C, 1 min; cool to 55-65°C, 1 min; 55-65°C, 1 min; and 72°C, 1 min. The primer sets used were mERa (positions 1354-1374; 5'-GGAGAT-TCTGATGATTGGTCT-3') and mERb (1812-1831; 5'-CATCTCCAGGAGCAGGTCAT-3'), mERo (661-682; 5'-TTCTGACAATCGACGCCAGAAT-3') and mERp (934-955; 5'-CATCATGCCCACTTCGTAACAC-3'), mPRa (2382-2403; 5'-CCCACAGGAGTTTGTCAAACTC-3') and mPRb (2687-2708; 5'-TAACTTCAGACATCATTTCCGG-3'), and RPL19A (5'-CTGAAGGTCAAAGGGAATGTG-3') and RPL19B (5'-GGACAGAGTCTTGATGATCTC-3') (19) . The PCR products (15 ,ul) SSC (20)/0.5% SDS at room temperature, 1 x SSC/0.5% SDS at 68°C, and 0.1 x SSC/0.1% SDS at 68°C. The blot was used to expose Kodak XAR film (Eastman Kodak) at -70°C.
RESULTS
Previous work used immunocytochemistry and immunoblotting methods to detect ER in mouse embryos as early as 13 days (23) and probably 10 days of gestation age. The sensitivity of these procedures is limited; therefore, to extend our investigation to the preimplantation embryo, the more sensitive RT-PCR technique was used in this study. Since both ER and PR are expressed in the female reproductive tract, it was crucial to avoid maternal cell contamination. In vitro cultured embryos were used to minimize this possible contamination. Cumulus cells, which also express ER, were removed from the eggs and the eggs were washed so that this source of contamination was avoided (data not shown). Further, unfertilized oocytes and one-cell embryos used for analysis were freed of zona pellucida and washed to eliminate any residual cumulus cells that might still have been associated with the zona even after hyaluronidase treatment. RNA from the uterus, in which both ER and PR are expressed, was used as a positive control.
ER mRNA Is Present at Both Early and Late Stages of Preimplantation Development. To determine whether the ER gene is expressed in preimplantation embryos, two sets of primers were used in the PCR analysis. One set of primers, mERo and mERp, is specific for the DNA-binding domain and will yield a DNA product of 295 bp. Since this primer set spans an intron, based on human ER genomic organization (24) , amplification of genomic DNA will not occur due to the large size of the intron (>10 kb). Therefore, a 295-bp band indicates the presence of ER mRNA in the original sample. Fig. 1A shows the result from PCR using this set of primers. None of the wash control lanes had any detectable signal, suggesting that no contamination occurred. A bright band of 295 bp was detected in the lane from the unfertilized oocyte. One-cell-and two-cell-embryo lanes also displayed this band, but the signal was less intense than that seen in the oocyte lane. This suggests that one-cell and two-cell embryos also have ER mRNA, though not as much as oocytes. However, there were no 295-bp fragments in the three-to four-cellembryo, the five-to eight-cell-embryo, or the morula lane.
A most interesting observation was the reoccurrence of the 295-bp fragment in the blastocyst lane, indicating that the ER gene is expressed at this stage. Southern blot analysis confirmed that the 295-bp band detected was indeed of ER origin (Fig. 1B) .
To further confirm these findings, another set of primers, mERa and mERb, specific for the steroid-binding domain of the receptor and spanning three introns, was used. A PCR product of 478 bp was expected. Fig. 1C essentially not detectable. The decrease in ER mRNA is not a result of dilution of ER mRNA due to cell division, because total RNA from the same number of embryos was assayed. The ER mRNA reappears at the blastocyst stage. Thus far there is only one known ER gene. Since our primers were chosen both in the DNA-binding domain and the steroidbinding domain, it is unlikely that we have detected forms of ER other than the classical nuclear ER. The Pattern of ER mRNA Expression Is Not a Result of Selective Sample Degradation. To ensure that all RNA samples were intact, we performed PCR on the same set of samples, using primers that amplify ribosomal protein L19 (RPL19) cDNA. Because ribosomal proteins should be expressed universally, failure to detect RPL19 mRNA would suggest that the sample was degraded. A band ofthe expected size (194 bp) was seen in all the appropriate lanes (Fig. 2) , indicating that embryos at all stages had the RPL19 mRNA. The expression of this gene seemed to increase somewhat during development, consistent with the role of ribosomal proteins in protein synthesis. The consistent detection of RPL19 gene expression in preimplantation embryos at all stages suggests that all the RNA samples were intact. A faint band in the wash control of the five-to eight-cell embryo suggested that minor contamination of an unknown source occurred in this sample.
The PR Gene Is Silent Until the Blastocyst Stage. The expression of the PR gene was examined by using a set of primers specific for the steroid-binding domain. This set of primers spans two introns, based on chicken PR genomic organization (25) , and should give a PCR product of 327 bp. No 327-bp band was detected in the lanes from the oocyte through the morula (Fig. 3A) . A band of 327 bp was visible only in the lane from the blastocyst. The specificity of the product was confirmed by Southern analysis (Fig. 3B) . Apparently, the PR gene is not expressed until the blastocyst stage during preimplantation development. This pattern of expression differs from that of the ER gene. niques. Fig. 4 summarizes our results and interpretations. ER mRNA exists in the unfertilized oocyte. The level of ER mRNA declines as the embryo develops. It is greatly diminished at the five-to eight-cell stage and is essentially undetectable at the morula stage. The observed decrease in ER mRNA is not due to dilution of the initial mRNA as the embryo proceeds through cell expansion, because the ER mRNA was assayed on a per-embryo basis.
Contrary to a previous report (16) , ER mRNA reappeared at the blastocyst stage. In comparison, the mRNA for the PR gene was not detectable in the earlier stages of embryonic development but did appear at the blastocyst stage. While RT-PCR does not provide strictly quantitative data, we believe that the following discussion is instructive. Based on the assumption that each uterine cell contains 10 pg of RNA, we used a ratio of 1.8 embryos to 5 uterine cells for analysis. On the basis of the intensity of the band seen on Southern blots (by /-scan or densitometry; data not shown), a rough estimate of ER mRNA levels in one oocyte is on the order of that found in 10 uterine cells. A blastocyst has an ER mRNA level comparable to that found in one uterine cell. The PR mRNA level in a blastocyst is comparable to that in one uterine cell. Since one blastocyst has 32- (17, 26, 27) . Since a high level of ER mRNA was detected in the unfertilized oocyte, it is reasonable to argue that the ER mRNA detected in the one-cell embryo was carried over from the oocyte where maternally synthesized mRNA is stored. The ER mRNA level declined from the two-cell to the five-to eight-cell stage. This is compatible with the general observation of loss of maternal RNA in early development (28) . Though the embryo is capable of synthesizing RNA from the two-cell to the fiveto eight-cell stage, the ER mRNA detected at these stages is __j Physiology: Hou and Gorski tu u not likely to be synthesized by the embryo, because the amount continues to decline. At the morula stage, ER mRNA is virtually undetectable. The reappearance of ER mRNA and appearance of PR mRNA in the blastocyst must be a result of embryonic RNA synthesis. At this stage, embryonic transcription is very active.
Implications for the Development and Implantation of Preimplantation Embryos. The differential expression of ER and PR genes during preimplantation development suggests that ER and PR may have different roles during this period. It is known that estrogen stimulates follicular growth in the process of oocyte maturation (29) . That both the cumulus cells and the oocyte express ER mRNA suggests that estrogen can influence both cell types. Blastocyst formation is an important period in preimplantation development. The embryo implants at the late blastocyst stage. It is interesting that the embryonic expression of the ER and the PR genes coincides with this time. Blastocyst-specific genes are expressed in the transition from morula to blastocyst, and this expression is required (30, 31) . There are also changes in the synthesis and secretion of stage-specific proteins from early to late blastocysts (5, 32) . Estrogen apparently is an important regulator in this process, since dormant blastocysts reactivated with estrogen undergo the same changes. The presence of estrogen seems necessary for the development of the embryo because antiestrogen or aromatase inhibitor can block embryo development (13, 14) . The function of estrogen might be to stimulate the development of the embryo and prepare it for implantation. This is consistent with the possible lethality of an ER mutation (1). The requirement for ER must go beyond the maternal source, since a homozygous ER mutant from herterozygous parents would be viable otherwise. The expression of the ER gene by the embryo itself must be crucial for survival.
Progesterone is also necessary for implantation in mice. Treatment with progesterone antagonists RU486 and ZK98734 prevents normal embryo transport and implantation, but progesterone is apparently not essential for development (33) . The timely expression of the PR gene in blastocysts implies that the effect of progesterone can be exerted on the embryo as well.
While this work was in progress, Wu et al. (16) reported that they could detect ER messages in oocytes and two-cell embryos, which is consistent with our findings, but they failed to detect any ER message at the blastocyst stage. This discrepancy could result from the sensitivity of the PCR methods, since we used "booster" PCR and a higher number of cycles, which should give greater sensitivity. They concluded that preimplantation embryos do not express ER and that any effect of estrogen on the embryo acts indirectly through the uterus, possibly through the regulation of growth factors and their receptors. Although the expression of growth factors and growth factor receptors (platelet-derived growth factor A, transforming growth factors a and A3, and epidermal growth factor receptor) in the embryo has been reported (18, 34, 35) , and in some cases, the expression was regulated by estrogen, it is not clear whether the effect was on the embryo directly or mediated through the uterus. Our results clearly demonstrate that the ER gene is expressed by preimplantation embryos. This finding provides a basis for the direct effect of estrogen on the embryo. Since both ER and PR genes are expressed at the blastocyst stage, a new perspective of the mechanism of implantation may be in order. Previous studies have focused largely on uterine response to hormones; our findings suggest an embryonic target for the hormones. Estrogen and progesterone may induce changes both in the uterus and in the embryo that lead to successful implantation.
